AngioDynamics Inc
ANGO13.100USD
-0.060-0.46%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
542.95MMarket Cap
LossP/E TTM
More Details of AngioDynamics Inc Company
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics Inc Info
Ticker SymbolANGO
Company nameAngioDynamics Inc
IPO dateMay 27, 2004
CEOClemmer (James C)
Number of employees675
Security typeOrdinary Share
Fiscal year-endMay 27
Address14 Plaza Drive
CityLATHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code12110
Phone15187981215
Websitehttps://www.angiodynamics.com/
Ticker SymbolANGO
IPO dateMay 27, 2004
CEOClemmer (James C)
Company Executives of AngioDynamics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
66.46M
87.78%
International
9.26M
12.22%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
Other
65.84%
Shareholders
Shareholders
Proportion
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
Other
65.84%
Shareholder Types
Shareholders
Proportion
Investment Advisor
36.53%
Investment Advisor/Hedge Fund
35.68%
Hedge Fund
21.31%
Individual Investor
6.44%
Research Firm
1.99%
Pension Fund
1.68%
Bank and Trust
0.25%
Venture Capital
0.06%
Insurance Company
0.03%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Divisadero Street Capital Management, LP
3.40M
8.24%
+2.44M
+253.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.96M
7.2%
-94.58K
-3.09%
Jun 30, 2025
Systematic Financial Management, L.P.
2.51M
6.09%
+12.62K
+0.51%
Jun 30, 2025
Point72 Asset Management, L.P.
1.95M
4.73%
+1.02M
+109.86%
Jun 30, 2025
The Vanguard Group, Inc.
2.49M
6.04%
-3.33K
-0.13%
Jun 30, 2025
Millennium Management LLC
2.15M
5.21%
+746.42K
+53.34%
Jul 16, 2025
Armistice Capital LLC
1.53M
3.71%
-566.18K
-27.04%
Jun 30, 2025
Segall Bryant & Hamill, LLC
1.36M
3.29%
-27.75K
-2.00%
Jun 30, 2025
Bastion Asset Management Inc.
959.04K
2.33%
+304.22K
+46.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.85%
+7.01K
+0.60%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion0.79%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.63%
Vanguard US Multifactor ETF
Proportion0.15%
iShares Micro-Cap ETF
Proportion0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.07%
Fidelity Enhanced Small Cap ETF
Proportion0.06%
Avantis US Small Cap Equity ETF
Proportion0.06%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.04%
iShares Russell 2000 Value ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of AngioDynamics Inc?
The top five shareholders of AngioDynamics Inc are:
Divisadero Street Capital Management, LP holds 3.40M shares, accounting for 8.24% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.96M shares, accounting for 7.20% of the total shares.
Systematic Financial Management, L.P. holds 2.51M shares, accounting for 6.09% of the total shares.
Point72 Asset Management, L.P. holds 1.95M shares, accounting for 4.73% of the total shares.
The Vanguard Group, Inc. holds 2.49M shares, accounting for 6.04% of the total shares.
Divisadero Street Capital Management, LP holds 3.40M shares, accounting for 8.24% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.96M shares, accounting for 7.20% of the total shares.
Systematic Financial Management, L.P. holds 2.51M shares, accounting for 6.09% of the total shares.
Point72 Asset Management, L.P. holds 1.95M shares, accounting for 4.73% of the total shares.
The Vanguard Group, Inc. holds 2.49M shares, accounting for 6.04% of the total shares.
What are the top three shareholder types of AngioDynamics Inc?
The top three shareholder types of AngioDynamics Inc are:
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
How many institutions hold shares of AngioDynamics Inc (ANGO)?
As of 2025Q4, 311 institutions hold shares of AngioDynamics Inc, with a combined market value of approximately 40.19M, accounting for 106.71% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -2.34%.
What is the biggest source of revenue for AngioDynamics Inc?
In FY2026Q1, the -- business generated the highest revenue for AngioDynamics Inc, amounting to -- and accounting for --% of total revenue.
